Presentation TCT 2013 Cangrelor Will Be the Answer for Most in the Acute Setting! Presenter: Robert Harrington October 31, 2013 REGISTER for free or LOG IN to view this content CAD Pharma Presentation TCT 2013 Up Next Presentation TCT 2013 REPRISE II: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis Presenter: Ian Meredith October 31, 2013 More slides + Presentation TCT 2013 Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know to Use Them Safely Presenter: Jonathan Halperin October 31, 2013 Presentation TCT 2015 Latest Innovations in ECMO and Escalation of Therapy Presenter: Jonathan M. Hill October 14, 2015 We Recommend
Presentation TCT 2013 REPRISE II: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis Presenter: Ian Meredith October 31, 2013
Presentation TCT 2013 Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know to Use Them Safely Presenter: Jonathan Halperin October 31, 2013
Presentation TCT 2015 Latest Innovations in ECMO and Escalation of Therapy Presenter: Jonathan M. Hill October 14, 2015